*Press releases are taken from the company websites.
*Titles may be translated independently.
*Please be aware that, since data is collected automatically, there is a possibility of omissions occurring.
*We would like to kindly inform you that we do not collect all press releases from companies.
| Ticker Code | Date | Title | Link |
|---|---|---|---|
| TSE:2269 | 11/28/2025 | Notice regarding orphan drug designation for anti-malignant tumor drug "HBI-8000" (generic name: tucidinostat) (401KB) | https://www.meiji-seika-pharma.co.jp/pressrelease/2025/detail/pdf/251128_01.pdf |
| TSE:4507 | 11/28/2025 | (Correction/Numerical Data Correction) Regarding some corrections to the “Second Quarter (Interim Period) Financial Results for the Fiscal Year Ending March 2026 [IFRS] (Consolidated)” | https://www.shionogi.com/jp/ja/news/2025/11/20251128_10.html |
| TSE:4507 | 11/28/2025 | Announcement of publication of SHIONOGI BUSINESS REPORT | https://www.shionogi.com/jp/ja/investors/ir-library/shionogi-business-report.html |
| TSE:4507 | 11/28/2025 | Shionogi & Co., Ltd. and Pixie Dust Technologies' joint invention receives the Invention Encouragement Award at the 2020 Kanto Regional Invention Awards ~ Modulated sound output device that generates Gamma Wave Sound™ from everyday sounds ~ | https://www.shionogi.com/jp/ja/news/2025/11/20251128.html |
| TSE:4528 | 11/28/2025 | The report for the second quarter of the 78th term has been posted on the "IR Library". | https://www.ono-pharma.com/ja/ir/library/shareholders_report.html |
| TSE:4534 | 11/28/2025 | interim report | https://ssl4.eir-parts.net/doc/4534/ir_material_for_fiscal_ym1/192792/00.pdf |
| TSE:4568 | 11/28/2025 | Information on the sustainability opinion exchange meeting has been posted. | https://www.daiichisankyo.co.jp/investors/ir_news/detail/index_7350.html |
| TSE:4568 | 11/28/2025 | November 28, 2025 Based on the Japan Pharmaceutical Manufacturers Association Transparency Guidelines, we have released payment information to medical institutions, etc. and patient organizations for fiscal year 2024. | https://www.daiichisankyo.co.jp/news/detail/index_7352.html |
| TSE:4578 | 11/28/2025 | Cancer Research Society, NEC, and Taiho Pharmaceutical sign a three-party joint research agreement to create a new cancer treatment vaccine using whole genome information ~Start development of common neoantigen cancer treatment vaccine~ | https://www.taiho.co.jp/release/2025/20251128.html |
| TSE:4886 | 11/28/2025 | November 28, 2025 "Wings of Women" Asuka Pharmaceutical 20th Anniversary Social Contribution Project "Citizens' Association for Cervical Cancer" 513.58 KB | https://www.aska-pharma.co.jp/news/filedownload.php?name=ad5cb614005af5c399920a28b7b265c4.pdf |
| TSE:2269 | 11/27/2025 | Notice of application for additional indication for cervical intraepithelial neoplasia for photodynamic therapy drug "Lezaphyrin® 100mg for injection" (598KB) | https://www.meiji-seika-pharma.co.jp/pressrelease/2025/detail/pdf/251127_02.pdf |
| TSE:2269 | 11/27/2025 | Intake of high-cocoa chocolate before high-intensity resistance exercise (strength training) has been found to quickly reduce arterial stiffness, which increases with exercise - Published in the international academic journal Journal of Exercise Science & | https://www.meiji.co.jp/corporate/pressrelease/2025/11_08/ |
| TSE:2269 | 11/27/2025 | Regarding the launch of “Bolzi® Tablets 2.5mg, 5mg, 10mg” (480KB) | https://www.meiji-seika-pharma.co.jp/pressrelease/2025/detail/pdf/251127_01.pdf |
| TSE:3401 | 11/27/2025 | Receives milestone fee from Bioprojet for initiation of clinical trials for candidate drug for the treatment of narcolepsy | https://www.teijin-pharma.co.jp/pressrelease/2025/20251127.pdf |
| TSE:4521 | 11/27/2025 | November 27, 2025 "106th term interim shareholder communication" has been posted | https://ssl4.eir-parts.net/doc/4521/ir_material_for_fiscal_ym1/192052/00.pdf |